세계의 오시머티닙 약물 시장예측 2021년-2026년

■ 영문 제목 : Global Osimertinib Drugs Market Growth 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02124 입니다.■ 상품코드 : LPI-2201K02124
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 81
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산￦4,941,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산￦7,411,500견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산￦9,882,000견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 오시머티닙 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (40mg, 80mg)와 용도별 시장규모 (병원, 약국) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 오시머티닙 약물 시장 점유율
- 지역별 오시머티닙 약물 시장규모
- 주요지역의 종류별 시장규모 (40mg, 80mg)
- 주요지역의 용도별 시장규모 (병원, 약국)
- 미주의 오시머티닙 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 오시머티닙 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 오시머티닙 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 오시머티닙 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 오시머티닙 약물 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
AstraZeneca
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Osimertinib Drugs will have significant change from previous year. By the most conservative estimates of global Osimertinib Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Osimertinib Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Osimertinib Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
40mg
80mg

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Drugs Store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AstraZeneca

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osimertinib Drugs Consumption 2016-2026
2.1.2 Osimertinib Drugs Consumption CAGR by Region
2.2 Osimertinib Drugs Segment by Type
2.2.1 40mg
2.2.2 80mg
2.3 Osimertinib Drugs Sales by Type
2.3.1 Global Osimertinib Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Osimertinib Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Osimertinib Drugs Sale Price by Type (2016-2021)
2.4 Osimertinib Drugs Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Osimertinib Drugs Sales by Application
2.5.1 Global Osimertinib Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Osimertinib Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Osimertinib Drugs Sale Price by Application (2016-2021)

3 Global Osimertinib Drugs by Company
3.1 Global Osimertinib Drugs Sales Market Share by Company
3.1.1 Global Osimertinib Drugs Sales by Company (2019-2021)
3.1.2 Global Osimertinib Drugs Sales Market Share by Company (2019-2021)
3.2 Global Osimertinib Drugs Revenue Market Share by Company
3.2.1 Global Osimertinib Drugs Revenue by Company (2019-2021)
3.2.2 Global Osimertinib Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Osimertinib Drugs Sale Price by Company
3.4 Global Manufacturers Osimertinib Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osimertinib Drugs Product Location Distribution
3.4.2 Players Osimertinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Osimertinib Drugs by Region
4.1 Global Osimertinib Drugs by Region
4.1.1 Global Osimertinib Drugs Sales by Region
4.1.2 Global Osimertinib Drugs Revenue by Region
4.2 Americas Osimertinib Drugs Sales Growth
4.3 APAC Osimertinib Drugs Sales Growth
4.4 Europe Osimertinib Drugs Sales Growth
4.5 Middle East & Africa Osimertinib Drugs Sales Growth

5 Americas
5.1 Americas Osimertinib Drugs Sales by Country
5.1.1 Americas Osimertinib Drugs Sales by Country (2016-2021)
5.1.2 Americas Osimertinib Drugs Revenue by Country (2016-2021)
5.2 Americas Osimertinib Drugs Sales by Type
5.3 Americas Osimertinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Osimertinib Drugs Sales by Region
6.1.1 APAC Osimertinib Drugs Sales by Region (2016-2021)
6.1.2 APAC Osimertinib Drugs Revenue by Region (2016-2021)
6.2 APAC Osimertinib Drugs Sales by Type
6.3 APAC Osimertinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Osimertinib Drugs by Country
7.1.1 Europe Osimertinib Drugs Sales by Country (2016-2021)
7.1.2 Europe Osimertinib Drugs Revenue by Country (2016-2021)
7.2 Europe Osimertinib Drugs Sales by Type
7.3 Europe Osimertinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Osimertinib Drugs by Country
8.1.1 Middle East & Africa Osimertinib Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Osimertinib Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Osimertinib Drugs Sales by Type
8.3 Middle East & Africa Osimertinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Osimertinib Drugs Distributors
10.3 Osimertinib Drugs Customer

11 Global Osimertinib Drugs Market Forecast
11.1 Global Osimertinib Drugs Forecast by Region
11.1.1 Global Osimertinib Drugs Forecast by Regions (2021-2026)
11.2.2 Global Osimertinib Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Osimertinib Drugs Forecast by Type
11.7 Global Osimertinib Drugs Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca
12.1.1 AstraZeneca Company Information
12.1.2 AstraZeneca Osimertinib Drugs Product Offered
12.1.3 AstraZeneca Osimertinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AstraZeneca Main Business Overview
12.1.5 AstraZeneca Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Osimertinib Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 40mg
Table 3. Major Players of 80mg
Table 4. Global Osimertinib Drugs Sales by Type (2016-2021) & (K Units)
Table 5. Global Osimertinib Drugs Sales Market Share by Type (2016-2021)
Table 6. Global Osimertinib Drugs Revenue by Type (2016-2021) & ($ million)
Table 7. Global Osimertinib Drugs Revenue Market Share by Type (2016-2021)
Table 8. Global Osimertinib Drugs Sale Price by Type (2016-2021)
Table 9. Global Osimertinib Drugs Sales by Application (2016-2021) & (K Units)
Table 10. Global Osimertinib Drugs Sales Market Share by Application (2016-2021)
Table 11. Global Osimertinib Drugs Value by Application (2016-2021)
Table 12. Global Osimertinib Drugs Revenue Market Share by Application (2016-2021)
Table 13. Global Osimertinib Drugs Sale Price by Application (2016-2021)
Table 14. Global Osimertinib Drugs Sales by Company (2019-2021) & (K Units)
Table 15. Global Osimertinib Drugs Sales Market Share by Company (2019-2021)
Table 16. Global Osimertinib Drugs Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Osimertinib Drugs Revenue Market Share by Company (2019-2021)
Table 18. Global Osimertinib Drugs Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Osimertinib Drugs Producing Area Distribution and Sales Area
Table 20. Players Osimertinib Drugs Products Offered
Table 21. Osimertinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Osimertinib Drugs Sales by Region (2016-2021) (K Units)
Table 25. Global Osimertinib Drugs Sales Market Share by Region (2016-2021)
Table 26. Global Osimertinib Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Osimertinib Drugs Revenue Market Share by Region (2016-2021)
Table 28. Americas Osimertinib Drugs Sales by Country (2016-2021) & (K Units)
Table 29. Americas Osimertinib Drugs Sales Market Share by Country (2016-2021)
Table 30. Americas Osimertinib Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Osimertinib Drugs Revenue Market Share by Country (2016-2021)
Table 32. Americas Osimertinib Drugs Sales by Type (2016-2021) & (K Units)
Table 33. Americas Osimertinib Drugs Sales Market Share by Type (2016-2021)
Table 34. Americas Osimertinib Drugs Sales by Application (2016-2021) & (K Units)
Table 35. Americas Osimertinib Drugs Sales Market Share by Application (2016-2021)
Table 36. APAC Osimertinib Drugs Sales by Region (2016-2021) & (K Units)
Table 37. APAC Osimertinib Drugs Sales Market Share by Region (2016-2021)
Table 38. APAC Osimertinib Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Osimertinib Drugs Revenue Market Share by Region (2016-2021)
Table 40. APAC Osimertinib Drugs Sales by Type (2016-2021) & (K Units)
Table 41. APAC Osimertinib Drugs Sales Market Share by Type (2016-2021)
Table 42. APAC Osimertinib Drugs Sales by Application (2016-2021) & (K Units)
Table 43. APAC Osimertinib Drugs Sales Market Share by Application (2016-2021)
Table 44. Europe Osimertinib Drugs Sales by Country (2016-2021) & (K Units)
Table 45. Europe Osimertinib Drugs Sales Market Share by Country (2016-2021)
Table 46. Europe Osimertinib Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Osimertinib Drugs Revenue Market Share by Country (2016-2021)
Table 48. Europe Osimertinib Drugs Sales by Type (2016-2021) & (K Units)
Table 49. Europe Osimertinib Drugs Sales Market Share by Type (2016-2021)
Table 50. Europe Osimertinib Drugs Sales by Application (2016-2021) & (K Units)
Table 51. Europe Osimertinib Drugs Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Osimertinib Drugs Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Osimertinib Drugs Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Osimertinib Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Osimertinib Drugs Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Osimertinib Drugs Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Osimertinib Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Osimertinib Drugs Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Osimertinib Drugs
Table 61. Key Application and Potential Industries of Osimertinib Drugs
Table 62. Key Challenges of Osimertinib Drugs
Table 63. Key Trends of Osimertinib Drugs
Table 64. Osimertinib Drugs Distributors List
Table 65. Osimertinib Drugs Customer List
Table 66. Global Osimertinib Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Osimertinib Drugs Consumption Market Forecast by Region
Table 68. Global Osimertinib Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Osimertinib Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Osimertinib Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Osimertinib Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Osimertinib Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Osimertinib Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Osimertinib Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Osimertinib Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Osimertinib Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Osimertinib Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Osimertinib Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Osimertinib Drugs Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Osimertinib Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Osimertinib Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Osimertinib Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Osimertinib Drugs Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Osimertinib Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Osimertinib Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 86. AstraZeneca Basic Information, Osimertinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. AstraZeneca Osimertinib Drugs Product Offered
Table 88. AstraZeneca Osimertinib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. AstraZeneca Main Business
Table 90. AstraZeneca Latest Developments
List of Figures
Figure 1. Picture of Osimertinib Drugs
Figure 2. Osimertinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osimertinib Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Osimertinib Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Osimertinib Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 40mg
Figure 10. Product Picture of 80mg
Figure 11. Global Osimertinib Drugs Sales Market Share by Type in 2020
Figure 12. Global Osimertinib Drugs Revenue Market Share by Type (2016-2021)
Figure 13. Osimertinib Drugs Consumed in Hospital
Figure 14. Global Osimertinib Drugs Market: Hospital (2016-2021) & (K Units)
Figure 15. Osimertinib Drugs Consumed in Drugs Store
Figure 16. Global Osimertinib Drugs Market: Drugs Store (2016-2021) & (K Units)
Figure 17. Global Osimertinib Drugs Sales Market Share by Application (2016-2021)
Figure 18. Global Osimertinib Drugs Revenue Market Share by Application in 2020
Figure 19. Osimertinib Drugs Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Osimertinib Drugs Revenue Market Share by Company in 2020
Figure 21. Global Osimertinib Drugs Sales Market Share by Regions (2016-2021)
Figure 22. Global Osimertinib Drugs Revenue Market Share by Region in 2020
Figure 23. Americas Osimertinib Drugs Sales 2016-2021 (K Units)
Figure 24. Americas Osimertinib Drugs Revenue 2016-2021 ($ Millions)
Figure 25. APAC Osimertinib Drugs Sales 2016-2021 (K Units)
Figure 26. APAC Osimertinib Drugs Revenue 2016-2021 ($ Millions)
Figure 27. Europe Osimertinib Drugs Sales 2016-2021 (K Units)
Figure 28. Europe Osimertinib Drugs Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Osimertinib Drugs Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Osimertinib Drugs Revenue 2016-2021 ($ Millions)
Figure 31. Americas Osimertinib Drugs Sales Market Share by Country in 2020
Figure 32. Americas Osimertinib Drugs Revenue Market Share by Country in 2020
Figure 33. Americas Osimertinib Drugs Sales Market Share by Type in 2020
Figure 34. Americas Osimertinib Drugs Sales Market Share by Application in 2020
Figure 35. United States Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Osimertinib Drugs Sales Market Share by Region in 2020
Figure 40. APAC Osimertinib Drugs Revenue Market Share by Regions in 2020
Figure 41. APAC Osimertinib Drugs Sales Market Share by Type in 2020
Figure 42. APAC Osimertinib Drugs Sales Market Share by Application in 2020
Figure 43. China Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Osimertinib Drugs Sales Market Share by Country in 2020
Figure 50. Europe Osimertinib Drugs Revenue Market Share by Country in 2020
Figure 51. Europe Osimertinib Drugs Sales Market Share by Type in 2020
Figure 52. Europe Osimertinib Drugs Sales Market Share by Application in 2020
Figure 53. Germany Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Osimertinib Drugs Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Osimertinib Drugs Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Osimertinib Drugs Sales Market Share by Application in 2020
Figure 62. Egypt Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Osimertinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
※본 조사보고서 [세계의 오시머티닙 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02124) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 오시머티닙 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

  • 세계의 일로프로스트 약물 시장예측 2021년-2026년
    LPI-2201K00058 / LP Information / 2021년 12월 / 본 조사보고서는 일로프로스트 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Iloprost Drugs will have significant change from previous year. By the most conservative estimates of global Iloprost Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 90 million in 2020. Over...
  • 세계의 골다공증 치료제 시장예측 2021년-2026년
    LPI-2201K02125 / LP Information / 2021년 12월 / 본 조사보고서는 골다공증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Osteoporosis Drugs will have significant change from previous year. By the most conservative estimates of global Osteoporosis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...
  • 세계의 불임 치료제 시장예측 2021년-2026년
    LPI-2201K00069 / LP Information / 2021년 12월 / 본 조사보고서는 불임 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Infertility Drugs will have significant change from previous year. By the most conservative estimates of global Infertility Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4687.8 million in 2020. Over...